This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer

This study is currently recruiting participants.
See Contacts and Locations
Verified May 2017 by Bryan Schneider, MD, Hoosier Cancer Research Network
Sponsor:
Collaborators:
Hoosier Cancer Research Network
Vera Bradley Foundation for Breast Cancer
Walther Cancer Institute
Strategic Research Initiative Grant through IUSCC
Information provided by (Responsible Party):
Bryan Schneider, MD, Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT02101385
First received: March 21, 2014
Last updated: May 2, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2021
  Estimated Primary Completion Date: June 2021 (Final data collection date for primary outcome measure)